Perform basic laboratory techniques including cell culture and assays (protein quantification, DNA isolation, reagents and buffers for various assays). $60,000… Click here to view original post… […]
The EM Microbiologist conducts quantitative and qualitative analysis of pharmaceutical industries Environment according to FDA, ISO, cGMP and Boston Analytical,…From… Click here to view original post… […]
From global research discoveries to clinical breakthroughs – our vision is to become the most influential life sciences company for… Click here to view original post… […]
Pulmazole is on track for Phase 2b study start in Q1 2023 PUR3100 Phase 1 study is underway with data anticipated in Q4 2022 Ends Q2 with $42.9 million in cash and cash equivalents LEXINGTON, Mass., Aug. 8, 2022 /PRNewswire/ — Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage… Click here to view original post… […]
Spectrix Analytical Services, LLC is seeking candidates for one long-term, permanent contract position with a large pharmaceutical client in Cambridge,… Click here to view original post… […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sesen Bio (Nasdaq: SESN) today reported operating results for the second quarter ended June 30, 2022. During the quarter, the Company paused clinical development of its lead asset, Vicineum™ for the treatment of non-muscle invasive bladder cancer (NMIBC), and turned its primary focus to the assessment of potential… Click here to view original post… […]
BURLINGTON, Mass.–(BUSINESS WIRE)–PharmaEssentia’s SURPASS-ET trial protocol evaluating ropeginterferon alfa-2b-njft in essential thrombocythemia (ET) is published in Future Oncology. Click here to view original post… […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced financial results for the second quarter ending June 30, 2022 and provided a corporate update. Jeff Baxter, VBI’s President and CEO commented: “Since the… Click here to view original post… […]
CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–The ongoing real-world PCG Study compares the clinical actionability of both tissue- and blood-based CGP to limited tissue testing in aNSCLC Click here to view original post… […]
The Quality Manager is responsible for managing multiple department activities with a high degree of independence, while providing oversight of… Click here to view original post… […]
Copyright © 2022 Biotech Networks, LLC
